RG1004070: Infusion of off-the-shelf ex vivo expanded cryopreserved progenitor cells to facilitate the engraftment of a single CCR5?32 homozygous or heterozygous cord blood unit in patients with HIV and hematological malignancies
What is the goal of the study?
This is a Phase II prospective, open label, multi-site, non-randomized study in which patients with HIV and hematological malignancies will be enrolled. This trial will focus on evaluating the safety of single unit cord blood transplant in patients with hematological malignancies and HIV infection in need of allogeneic stem cell transplant (alloSCT) when the non-matched off-the-shelf (OTS) ex vivo expanded cryopreserved progenitor cells are infused.
Who can participate in the study?
Please contact the study team listed below to learn more.